Apple has been accused of patent infringement in relation to its built-in blood oxygen sensors by medical company Masimo. As a result, the International Trade Commission (ITC) has ordered a ban on the import of Series 9 and Ultra 2 models into the United States, effective from October. However, if President Joe Biden approves, the ban will go into effect on December 25, prohibiting the sale of these watch models.
Apple has rejected the accusations, stating that Masimo is using the ITC to prevent millions of American consumers from accessing a potentially life-saving product, while promoting its own watch, which mimics Apple’s design. Despite the ban, Apple has announced that it will continue its efforts to appeal the decision and believes it should be overturned.
In response to the ban, an Apple representative expressed the company’s disagreement, stating that they are exploring various legal and technical solutions to ensure the availability of Apple Watch for customers. If the ban is upheld, Apple will make every effort to quickly return Series 9 and Ultra 2 watches to customers in the United States.
It is worth noting that although Apple will be limited in selling these specific models of watches, other retailers will still have the ability to sell Series 9 and Ultra 2 watches, unless President Biden approves the ban.
Frequently Asked Questions (FAQ):
1. Who accused Apple of patent infringement?
The company that accused Apple of patent infringement is Masimo, a manufacturer of medical technology equipment.
2. What kind of ban did the International Trade Commission (ITC) impose?
The ITC ordered a ban on the import of Series 9 and Ultra 2 Apple Watch models into the United States.
3. What consequences can this legal battle have for the wearable devices industry?
The resolution of this case between Masimo and Apple could have significant implications for the wearable devices industry, especially in terms of patent infringement and intellectual property rights protection.
Source:
https://www.example.com
The source of the article is from the blog combopop.com.br